Neurocrine Biosciences, Inc. (NBIX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 14.11B |
| Enterprise Value | 13.81B |
| P/E Ratio | 24.09 |
| PEG Ratio | 0.2 |
| Price/Sales Ratio | 5.24 |
| Price/Book Ratio | 4.77 |
| Enterprise/Revenue | 5.28 |
| Enterprise/EBITDA | 17.15 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.22 |
| Operating Margin | 0.25 |
| Return On Assets | 0.14 |
| Return On Equity | 0.22 |
| Revenue | 2.86B |
| Revenue/Share | 30.87 |
| Gross Profit | 2.81B |
| EBITDA | 666.6M |
| Net Income | 478.6M |
| Diluted EPS | 4.67 |
| Total Cash | 1.32B |
| Total Cash/Share | 13.1 |
| Total Debt | 406.2M |
| Total Debt/Equity | 0.12 |
| Current Ratio | 2.93 |
| Book Value Per Share | 33.9 |
| 52-Week Change | 28.47 |
| 52-Week High | 169.57 |
| 52-Week Low | 122.14 |
| Moving Average 50 Days | 148.15 |
| Moving Average 200 Days | 141.41 |
| Average Volume | 1.2M |
| Shares Outstanding | 100.55M |
| % Held by Institutions | 100.43 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |